Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-16T23:58:21.646Z Has data issue: false hasContentIssue false

Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy

Published online by Cambridge University Press:  29 September 2025

April Dyer*
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USADuke Antimicrobial Stewardship Outreach Network (DASON), Durham, NC, USA
Elizabeth Dodds-Ashley
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USADuke Antimicrobial Stewardship Outreach Network (DASON), Durham, NC, USA
Angelina Davis
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USADuke Antimicrobial Stewardship Outreach Network (DASON), Durham, NC, USA
Melissa Johnson
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USADuke Antimicrobial Stewardship Outreach Network (DASON), Durham, NC, USA
Travis Jones
Affiliation:
University of North Carolina Medical Center, Chapel Hill, NC, USA
Rebekah W. Moehring
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USADuke Antimicrobial Stewardship Outreach Network (DASON), Durham, NC, USA
*
Corresponding author: April Dyer; Email: april.dyer@duke.edu

Abstract

Our novel antibiotic use denominator, targeted antimicrobial use admission, is defined as an inpatient admission in which a select agent or group of agents is administered. Used in combination with length of therapy, it allows programs to quickly assess agent inpatient durations.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Figure 1.Targeted antimicrobial use admission calculated among all antimicrobial agents, anti-MRSA agents, and IV vancomycin. Each blue figure represents 1,000 admissions. Each blue pill bottle represents 10,000 DOT.